Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Meisel

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Journal of Clinical Medicine|December 22, 2019
HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3Ricarda Ising, Sandra Weinhold, Sabrina Bianca Bennstein, et al.
Blood|August 29, 2014
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapseFlorian Babor, Angela R Manser, Johannes C Fischer, et al.
Molecular and Cellular Pediatrics|August 12, 2016
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileusTobias Gyárfás, Juergen Wintgens, Wolfgang Biskup, et al.
British Journal of Haematology|July 9, 2013
Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemiaFriedhelm R Schuster, Roland Meisel, Monika Führer, et al.
Clinical Immunology (Orlando, Fla.)|March 27, 2014
Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatmentSujal Ghosh, Friedhelm R Schuster, Ortwin Adams, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2015
De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephalyMichaela Kuhlen, Andrea Hönscheid, Loizos Loizou, et al.
Pharmacoeconomics - Open|January 3, 2025
Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in GermanyChuka Udeze, Nanxin Li, Colin Kunzweiler, et al.
Bone Marrow Transplantation|March 4, 2021
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantationSarah B Reusing, Angela R Manser, Stefanie Groeneveld-Krentz, et al.
British Journal of Haematology|December 16, 2014
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignanciesFriedhelm R Schuster, Michael Stanglmaier, Wilhelm Woessmann, et al.
Stem Cells Translational Medicine|April 29, 2026
Differentiation of cord blood-derived Innate Lymphoid Cells 1  into KIR+NKG2A- natural killer cells in a human stem cell nicheSabrina B Bennstein, Julian Reiß, Sandra Weinhold, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Journal of Clinical Medicine|December 22, 2019
HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3Ricarda Ising, Sandra Weinhold, Sabrina Bianca Bennstein, et al.
Blood|August 29, 2014
KIR ligand C2 is associated with increased susceptibility to childhood ALL and confers an elevated risk for late relapseFlorian Babor, Angela R Manser, Johannes C Fischer, et al.
Molecular and Cellular Pediatrics|August 12, 2016
Transient spontaneous remission in congenital MLL-AF10 rearranged acute myeloid leukemia presenting with cardiorespiratory failure and meconium ileusTobias Gyárfás, Juergen Wintgens, Wolfgang Biskup, et al.
British Journal of Haematology|July 9, 2013
Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemiaFriedhelm R Schuster, Roland Meisel, Monika Führer, et al.
Clinical Immunology (Orlando, Fla.)|March 27, 2014
Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatmentSujal Ghosh, Friedhelm R Schuster, Ortwin Adams, et al.
Clinical Immunology (Orlando, Fla.)|November 4, 2015
De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephalyMichaela Kuhlen, Andrea Hönscheid, Loizos Loizou, et al.
Pharmacoeconomics - Open|January 3, 2025
Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in GermanyChuka Udeze, Nanxin Li, Colin Kunzweiler, et al.
Bone Marrow Transplantation|March 4, 2021
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantationSarah B Reusing, Angela R Manser, Stefanie Groeneveld-Krentz, et al.
British Journal of Haematology|December 16, 2014
Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignanciesFriedhelm R Schuster, Michael Stanglmaier, Wilhelm Woessmann, et al.
Stem Cells Translational Medicine|April 29, 2026
Differentiation of cord blood-derived Innate Lymphoid Cells 1  into KIR+NKG2A- natural killer cells in a human stem cell nicheSabrina B Bennstein, Julian Reiß, Sandra Weinhold, et al.
Pageof 13